Inventor
TAIT BRADLEY
US21 patents
⚠️ This page may combine multiple inventors who share the name “TAIT BRADLEY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PROTEOSTASIS THERAPEUTICS INC
14 patentsUS10392378B2Aug 27, 2019
Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis
PROTEOSTASIS THERAPEUTICS INC7 citations84
US10392372B2Aug 27, 2019
Compounds, compositions, and methods for increasing CFTR activity
PROTEOSTASIS THERAPEUTICS INC6 citations84
US10174014B2Jan 8, 2019
Compounds, compositions, and methods for increasing CFTR activity
PROTEOSTASIS THERAPEUTICS INC9 citations84
US10017503B2Jul 10, 2018
Compounds, compositions, and methods for increasing CFTR activity
PROTEOSTASIS THERAPEUTICS INC11 citations84
US9790219B2Oct 17, 2017
Compounds, compositions, and methods for increasing CFTR activity
PROTEOSTASIS THERAPEUTICS INC16 citations84
US9745292B2Aug 29, 2017
Compounds, compositions, and methods for increasing CFTR activity
PROTEOSTASIS THERAPEUTICS INC14 citations84
US10344023B2Jul 9, 2019
Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis
PROTEOSTASIS THERAPEUTICS INC6 citations73
US11242361B2Feb 8, 2022
Proteasome activity enhancing compounds
PROTEOSTASIS THERAPEUTICS INC2 citations71
US11098035B2Aug 24, 2021
Compounds, compositions, and methods for increasing CFTR activity
PROTEOSTASIS THERAPEUTICS INC0 citations62
US10738011B2Aug 11, 2020
Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis
PROTEOSTASIS THERAPEUTICS INC1 citations62
US10738040B2Aug 11, 2020
Compounds, compositions, and methods for increasing CFTR activity
PROTEOSTASIS THERAPEUTICS INC1 citations62
US11746098B2Sep 5, 2023
Proteasome activity enhancing compounds
PROTEOSTASIS THERAPEUTICS INC1 citations60
US10532996B2Jan 14, 2020
Proteostasis regulators
PROTEOSTASIS THERAPEUTICS INC0 citations50
US9399647B2Jul 26, 2016
Proteasome activity modulating compounds
PROTEOSTASIS THERAPEUTICS INC0 citations40